目的：评价米氮平治疗伴抑郁的心血管神经症的临床疗效和安全性。
Objective: To evaluate the efficacy and safety of mirtazapine in the treatment of cardiovascular neurosis with depression.
采用综合性医院焦虑抑郁量表进行测评，该量表由2个分量表14个项目组成，其中焦虑分量表7个项目，突出神经症的精神症状；
They were assessed with the Hospital Anxiety and Depression Scale, which composed of 2 subscales and 14 items. In the anxiety subscale, there were 7 items focused on psychiatric symptoms of neurosis;
应用推荐